Trials / Completed
CompletedNCT03911921
RSYR for Fatigue Reduction in Cancer Survivors
Renshen Yangrong Tang (RSYRT) for Reducing Fatigue in Cancer Survivors: A Phase II Randomized Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This randomized Phase II trial to establish the efficacy of traditional Chinese medicine (TCM) herbal products above control group for treating fatigue in patients with cancer.
Detailed description
Patients who were randomized and been enrolled in, had stable disease and no anemia, and reported moderate to severe fatigue over two months (rated ≥4 on a 0-10 scale). Patients took TCM decoction Renshen Yangrong decoction (RSYR),Which containing 12 TCM herbs, twice a day for 6 weeks. RSYRT aims to correct Qi deficiency. Fatigue was assessed before and after RSYRT therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RSYRT decoction | Compound granules of traditional Chinese medicine |
| DRUG | Astragalus membranaceus | One herb |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2019-04-11
- Last updated
- 2019-04-16
Source: ClinicalTrials.gov record NCT03911921. Inclusion in this directory is not an endorsement.